A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab refractory esophagogastric (EG) cancer Meeting Abstract
| Authors: | Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Boyar, M. S.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Imtiaz, T.; Berger, M. F.; Vakiani, E. |
| Abstract Title: | A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab refractory esophagogastric (EG) cancer |
| Meeting Title: | 2015 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2015 Jan 15-17 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-01-20 |
| Language: | English |
| ACCESSION: | WOS:000356883800058 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.3_suppl.59 |
| Notes: | Meeting Abstract: 59 -- Source: Wos |
